tiprankstipranks
Trending News
More News >
Prestige Consumer Healthcare (PBH)
NYSE:PBH
US Market
Advertisement

Prestige Consumer Healthcare (PBH) Ratios

Compare
114 Followers

Prestige Consumer Healthcare Ratios

PBH's free cash flow for Q4 2025 was $0.59. For the 2025 fiscal year, PBH's free cash flow was decreased by $ and operating cash flow was $0.29. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
4.38 3.20 2.44 2.04 2.21
Quick Ratio
2.99 2.02 1.43 1.21 1.27
Cash Ratio
1.27 0.40 0.36 0.19 0.26
Solvency Ratio
0.15 0.14 -0.02 0.12 0.10
Operating Cash Flow Ratio
2.51 2.13 1.43 1.81 1.93
Short-Term Operating Cash Flow Coverage
32.06 0.00 23.54 28.53 27.90
Net Current Asset Value
$ -1.10B$ -1.29B$ -1.51B$ -1.80B$ -1.80B
Leverage Ratios
Debt-to-Assets Ratio
0.01 0.34 0.41 0.41 0.44
Debt-to-Equity Ratio
0.03 0.69 0.94 0.95 1.12
Debt-to-Capital Ratio
0.03 0.41 0.49 0.49 0.53
Long-Term Debt-to-Capital Ratio
0.02 0.40 0.48 0.48 0.52
Financial Leverage Ratio
1.85 2.00 2.32 2.33 2.52
Debt Service Coverage Ratio
5.30 4.57 0.33 4.01 2.98
Interest Coverage Ratio
7.53 5.10 4.99 5.13 3.61
Debt to Market Cap
0.02 0.32 0.43 0.56 0.67
Interest Debt Per Share
1.91 24.25 28.79 31.25 31.81
Net Debt to EBITDA
-0.25 2.92 92.25 4.21 4.78
Profitability Margins
Gross Profit Margin
56.64%55.49%55.45%57.11%58.03%
EBIT Margin
23.24%30.50%-2.19%29.84%29.86%
EBITDA Margin
31.88%33.22%1.26%32.35%32.90%
Operating Profit Margin
30.04%30.43%30.63%30.36%31.53%
Pretax Profit Margin
25.67%24.53%-8.33%24.15%21.64%
Net Profit Margin
19.02%18.60%-7.30%18.90%17.46%
Continuous Operations Profit Margin
14.78%18.60%-7.30%18.90%17.46%
Net Income Per EBT
74.07%75.84%87.64%78.25%80.68%
EBT Per EBIT
85.46%80.61%-27.19%79.55%68.63%
Return on Assets (ROA)
6.21%6.31%-2.45%5.60%4.80%
Return on Equity (ROE)
11.82%12.65%-5.69%13.02%12.12%
Return on Capital Employed (ROCE)
10.13%10.70%10.82%9.35%8.99%
Return on Invested Capital (ROIC)
7.48%8.10%9.42%7.28%7.22%
Return on Tangible Assets
35.01%44.53%-17.00%51.99%43.86%
Earnings Yield
6.37%5.87%-2.63%7.72%7.44%
Efficiency Ratios
Receivables Turnover
6.65 6.37 6.75 7.80 8.23
Payables Turnover
21.87 12.85 8.01 8.36 8.61
Inventory Turnover
3.17 3.61 3.10 3.87 3.44
Fixed Asset Turnover
8.97 12.60 12.60 11.03 9.18
Asset Turnover
0.33 0.34 0.34 0.30 0.28
Working Capital Turnover Ratio
3.14 4.60 5.92 7.31 5.19
Cash Conversion Cycle
153.26 130.01 126.25 97.36 107.97
Days of Sales Outstanding
54.87 57.34 54.06 46.79 44.37
Days of Inventory Outstanding
115.08 101.08 117.78 94.23 105.99
Days of Payables Outstanding
16.69 28.40 45.58 43.66 42.39
Operating Cycle
169.95 158.42 171.83 141.02 150.36
Cash Flow Ratios
Operating Cash Flow Per Share
5.57 5.00 4.61 5.17 4.69
Free Cash Flow Per Share
5.41 4.81 4.45 4.98 4.25
CapEx Per Share
0.16 0.19 0.16 0.19 0.44
Free Cash Flow to Operating Cash Flow
0.97 0.96 0.97 0.96 0.91
Dividend Paid and CapEx Coverage Ratio
34.86 26.07 29.51 26.96 10.59
Capital Expenditure Coverage Ratio
34.86 26.07 29.51 26.96 10.59
Operating Cash Flow Coverage Ratio
5.52 0.22 0.17 0.17 0.16
Operating Cash Flow to Sales Ratio
0.25 0.22 0.20 0.24 0.25
Free Cash Flow Yield
8.05%6.71%7.10%9.41%9.64%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
15.70 17.04 -37.96 12.96 13.44
Price-to-Sales (P/S) Ratio
2.97 3.17 2.77 2.45 2.35
Price-to-Book (P/B) Ratio
1.80 2.15 2.16 1.69 1.63
Price-to-Free Cash Flow (P/FCF) Ratio
12.43 14.90 14.08 10.63 10.37
Price-to-Operating Cash Flow Ratio
12.13 14.33 13.60 10.24 9.39
Price-to-Earnings Growth (PEG) Ratio
-33.92 -0.05 0.27 0.52 0.80
Price-to-Fair Value
1.80 2.15 2.16 1.69 1.63
Enterprise Value Multiple
9.07 12.46 312.49 11.77 11.91
Enterprise Value
3.24B 4.66B 4.43B 4.14B 3.70B
EV to EBITDA
9.07 12.46 312.49 11.77 11.91
EV to Sales
2.89 4.14 3.93 3.81 3.92
EV to Free Cash Flow
12.09 19.47 19.97 16.54 17.32
EV to Operating Cash Flow
11.75 18.72 19.30 15.93 15.69
Tangible Book Value Per Share
-19.56 -23.98 -28.51 -33.78 -33.77
Shareholders’ Equity Per Share
37.50 33.26 29.01 31.39 27.05
Tax and Other Ratios
Effective Tax Rate
0.26 0.24 0.12 0.22 0.19
Revenue Per Share
22.64 22.62 22.61 21.62 18.79
Net Income Per Share
4.31 4.21 -1.65 4.09 3.28
Tax Burden
0.74 0.76 0.88 0.78 0.81
Interest Burden
1.10 0.80 3.79 0.81 0.72
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.10 0.09 0.10 0.10 0.09
Stock-Based Compensation to Revenue
0.01 0.01 0.01 <0.01 <0.01
Income Quality
1.29 1.19 -2.79 1.27 1.43
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis